MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
form 
Route of 
administration 
Immediate 
packaging 
Pack size 
EU/1/17/1221/001 
EU/1/17/1221/002 
EU/1/17/1221/003 
EU/1/17/1221/004 
EU/1/17/1221/005 
EU/1/17/1221/006 
EU/1/17/1221/007 
Kisqali 
Kisqali 
Kisqali 
Kisqali 
Kisqali 
Kisqali 
Kisqali 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
200 mg 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Film-coated tablet 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
Oral use 
blister (PCTFE/PVC) 
21 tablets 
blister (PA/alu/PVC)  21 tablets 
blister (PCTFE/PVC) 
42 tablets 
blister (PA/alu/PVC)  42 tablets 
blister (PCTFE/PVC) 
63 tablets 
blister (PA/alu/PVC)  63 tablets 
blister (PCTFE/PVC) 
63 (3 x 21) tablets 
(multipack) 
EU/1/17/1221/008 
Kisqali 
200 mg 
Film-coated tablet 
Oral use 
blister (PA/alu/PVC)  63 (3 x 21) tablets 
EU/1/17/1221/009 
Kisqali 
200 mg 
Film-coated tablet 
Oral use 
blister (PCTFE/PVC) 
(multipack) 
126 (3 x 42) 
tablets (multipack) 
EU/1/17/1221/010 
Kisqali 
200 mg 
Film-coated tablet 
Oral use 
blister (PA/alu/PVC)  126 (3 x 42) 
EU/1/17/1221/011 
Kisqali 
200 mg 
Film-coated tablet 
Oral use 
blister (PCTFE/PVC) 
tablets (multipack) 
189 (3 x 63) 
tablets (multipack) 
EU/1/17/1221/012 
Kisqali 
200 mg 
Film-coated tablet 
Oral use 
blister (PA/alu/PVC)  189 (3 x 63) 
tablets (multipack) 
1/1 
 
 
 
